Serum Levels of 8-Iso-Prostaglandin F2α and Raftlin in Patients with Generalized Anxiety Disorder
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: Although there are neurobiological studies of patients with generalized anxiety disorder (GAD), the topic is still open to research. Lipid peroxidation can generate new molecular signal sequences by altering protein amounts and activity. 8-Iso-Prostaglandin F2α (8-iso-PGF2α) is known to be an important lipid peroxidation marker. Raftlin, which is defined as a major lipid raft protein, is important for the regulation of signal transduction and inflammatory processes. Methods: Our aim in this study was to compare the 8-iso-PGF2α and Raftlin levels of forty patients diagnosed with GAD and 40 healthy controls (age-sex and body mass index-matched). Results: In the present study, increased serum 8-iso-PGF2α and Raftlin levels were found in patients with GAD compared to healthy controls. Conclusion: To our knowledge, this is the first study to examine 8-iso-PGF2α and Raftlin levels in patients with GAD. These results expand our knowledge of oxidative stress and inflammatory processes in patients with GAD. Our study should be considered preliminary and further studies should be performed with larger sample groups comparing values before and after treatment.
Abstract
Objective: Although there are neurobiological studies of patients with generalized anxiety disorder (GAD), the topic is still open to research. Lipid peroxidation can generate new molecular signal sequences by altering protein amounts and activity. 8-Iso-Prostaglandin F2α (8-iso-PGF2α) is known to be an important lipid peroxidation marker. Raftlin, which is defined as a major lipid raft protein, is important for the regulation of signal transduction and inflammatory processes. Methods: Our aim in this study was to compare the 8-iso-PGF2α and Raftlin levels of forty patients diagnosed with GAD and 40 healthy controls (age-sex and body mass index-matched). Results: In the present study, increased serum 8-iso-PGF2α and Raftlin levels were found in patients with GAD compared to healthy controls. Conclusion: To our knowledge, this is the first study to examine 8-iso-PGF2α and Raftlin levels in patients with GAD. These results expand our knowledge of oxidative stress and inflammatory processes in patients with GAD. Our study should be considered preliminary and further studies should be performed with larger sample groups comparing values before and after treatment.
참고문헌 (35)
- Wittchen HU, "Size and burden of mental disorders in Europe--a critical review and appraisal of 27 studies", Eur Neuropsychopharmacol, 15, pp.357~376 (2005)
- Weinberger DR, "Anxiety at the frontier of molecular medicine", N Engl J Med, 344, pp.1247~1249 (2001)
- Valko M, "Free radicals and antioxidants in normal physiological functions and human disease", Int J Biochem Cell Biol, 39, pp.44~84 (2007)
- Tabak O, "Oxidative lipid, protein, and DNA damage as oxidative stress markers in vascular complications of diabetes mellitus", Clin Invest Med, 34, pp.E163~E171 (2011)
- Wang Y, "Redox sensing by proteins : oxidative modifications on cysteines and the consequent events", Antioxid Redox Signal, 16, pp.649~657 (2012)
- Morris G, "The deleterious effects of oxidative and nitrosative stress on palmitoylation, membrane lipid rafts and lipid-based cellular signalling : new drug targets in neuroimmune disorders", Mol Neurobiol, 53, pp.4638~4658 (2016)
- Gào X, "Urinary 8-isoprostane levels and occurrence of lung, colorectal, prostate, breast and overall cancer : results from a large, population-based cohort study with 14 years of follow-up", Free Radic Biol Med, 123, pp.20~26 (2018)
- van 't Erve TJ, "Reinterpreting the best biomarker of oxidative stress : the 8-iso-PGF(2α)", PGF(2α)ratio distinguishes chemical from enzymatic lipid peroxidation, 2015, pp.83, 245~251
- Maes M, "Generalized anxiety disorder(GAD)and comorbid major depression with GAD are characterized by enhanced nitro-oxidative stress, increased lipid peroxidation, and lowered lipid-associated antioxidant defenses", Neurotox Res, 34, pp.489~510 (2018)
- Fedoce ADG, "The role of oxidative stress in anxiety disorder : cause or consequence?", Free Radic Res, 52, pp.737~750 (2018)
- Salaun C, "The intracellular dynamic of protein palmitoylation", J Cell Biol, 191, pp.1229~1238 (2010)
- Lingwood D, "Lipid rafts as a membrane-organizing principle", Science, 327, pp.46~50 (2010)
- Le PU, "Caveolin-1 is a negative regulator of caveolae-mediated endocytosis to the endoplasmic reticulum", J Biol Chem, 277, pp.3371~3379 (2002)
- Favilla C, "Chronic Galphas signaling in the striatum increases anxiety-related behaviors independent of developmental effects", J Neurosci, 28, pp.13952~13956 (2008)
- Saeki K, "The B cellspecific major raft protein, Raftlin, is necessary for the integrity of lipid raft and BCR signal transduction", EMBO J, 22, pp.3015~3026 (2003)
- Lee W, "Raftlin : a new biomarker in human sepsis", Inflammation, 37, pp.706~711 (2014)
- Buchmayer F, "Amphetamine actions at the serotonin transporter rely on the availability of phosphatidylinositol-4, 5-bisphosphate", Proc Natl Acad Sci U S A, 110, pp.11642~11647 (2013)
- Gibney SM, "Poly I : C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression", Brain Behav Immun, 28, pp.170~181 (2013)
- Hou R, "Peripheral inflammatory cytokines and immune balance in Generalised Anxiety Disorder : case-controlled study", Brain Behav Immun, 62, pp.212~218 (2017)
- Tang Z, "Peripheral proinflammatory cytokines in Chinese patients with generalised anxiety disorder", J Affect Disord, 225, pp.593~598 (2018)
- Costello H, "Systematic review and meta-analysis of the association between peripheral inflammatory cytokines and generalised anxiety disorder", BMJ Open, 9, pp.e027925~ (2019)
- Dimopoulos N, "Increased plasma levels of 8-iso-PGF2alpha and IL-6 in an elderly population with depression", Psychiatry Res, 161, pp.59~66 (2008)
- Yager S, "Depression and oxidative damage to lipids", Psychoneuroendocrinology, 35, pp.1356~1362 (2010)
- American Psychiatric Association, "Diagnostic and statistical manual of mental disorders", pp.591~643 (2013), American Psychiatric Association
- Rammal H, "Evidence that oxidative stress is linked to anxiety-related behaviour in mice", Brain Behav Immun, 22, pp.1156~1159 (2008)
- Hassan W, "Association between oxidative stress and contextual fear conditioning in Carioca high-and lowconditioned freezing rats", Brain Res, 1512, pp.60~67 (2013)
- Hovatta I, "Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice", Nature, 438, pp.662~666 (2005)
- Emhan A, "Evaluation of oxidative and antioxidative parameters in generalized anxiety disorder", Psychiatry Res, 230, pp.806~810 (2015)
- Ercan AC, "Oxidative status and prolidase activities in generalized anxiety disorder", Asian J Psychiatr, 25, pp.118~122 (2017)
- Bulut M, "Reduced PON1 enzymatic activity and increased lipid hydroperoxide levels that point out oxidative stress in generalized anxiety disorder", J Affect Disord, 150, pp.829~833 (2013)
- Ebru Fındıklı, "The Diagnostic Value of Malondialdehyde, Superoxide Dismutase and Catalase Activity in Drug Naïve, First Episode, Non-Smoker Generalized Anxiety Disorder Patients", Clinical Psychopharmacology and Neuroscience, 16(1), pp.88~94 (2018), 대한정신약물학회[DOI]
- Jordan W, "Oxidative stress in drug-naïve first episode patients with schizophrenia and major depression : effects of disease acuity and potential confounders", Eur Arch Psychiatry Clin Neurosci, 268, pp.129~143 (2018)
- Wray NH, "Lipid rafts in psychiatry", Adv Pharmacol, 86, pp.21~45 (2019)
- Watanabe A, "Raftlin is involved in the nucleocapture complex to induce poly(I : C)-mediated TLR3 activation", J Biol Chem, 286, pp.10702~10711 (2011)
- Kim JW, "Diagnostic utility of quantitative EEG in un-medicated schizophrenia", Neurosci Lett, 589, pp.126~131 (2015)
